Provention Bio to Present at Two Upcoming Virtual Investor Conferences News provided by Share this article Share this article RED BANK, N.J., March 4, 2021 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced that management will participate in two upcoming virtual investor conferences in March. H.C. Wainwright Global Life Sciences Conference Andrew Drechsler, Provention Bio's Chief Financial Officer will provide a corporate update at the H.C. Wainwright Global Life Sciences Conference. The webcast will be available beginning Tuesday, March 9, 2021, at 7:00 am E.T and can be accessed by visiting the Events and Webcasts section of the Company's website: http://investors.proventionbio.com/events.